Montu’s vice president, Rhys Staley, denies unethical practices and financial inducements for doctors to prescribe in-house products. He defends the company’s dedication to quality care and collaboration with the industry. Staley emphasises patient screening and access to free nurse advice. He also addresses concerns about product quality and patient education. Staley reiterates Montu’s openness to collaboration.
Read the full story here
Written by: Steve Jones
Published on March 13, 2024 at 08:17AM
Source: Cannabiz (opens in new tab)